Other top stories

Man With Rare Genetic Mutation Shows Unprecedented Resistance to Alzheimer’s

May 17, 2023

World's Oldest Practicing Doctor Offers Advice on Staying Mentally Sharp

May 16, 2023

The Weekly Mind Reader: Depression Treatment Priorities

May 12, 2023

How a Club for Parkinson’s Patients Helps Build Empowerment Through Connection

May 11, 2023

Mental Health Counseling Approach Meets College Students Where They Live

May 10, 2023

Death on a NYC Subway Highlights Need for Urgent Action on Homelessness, Mental Health

May 9, 2023

Other stories

The Advantages of Long-Acting Injectables in Early-Phase Schizophrenia

May 8, 2023

Smiley Emojis Sometimes Mask Sad Feelings, Study Finds

May 8, 2023

The Weekly Mind Reader: Ghrelin, Anxiety, and Disordered Eating

May 5, 2023

Experimental Alzheimer's Drug Donanemab Shows Promise in Slowing Cognitive Decline

May 4, 2023

A Reason for Hope in Rett Syndrome: New Medications, Novel Gene Therapies

May 3, 2023

Slow-Release UZEDY Gains FDA Approval, Reduces Schizophrenia Relapse by 80%

May 2, 2023

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe